FDA

RSS

The U.S. Food and Drug Administration issued a conclusion on slick-hair cattle, its first enforcement discretion decision for an intentional genomic alteration in an animal for food use.

USDA-FSIS and FDA have started to share information on whole genome sequencing. Also, FSIS and CDC are working to enhance data sharing on critically important public health activities.

The U.S. Food and Drug Administration (FDA) is investigating cases concerning powdered infant formula, as it may have caused Cronobacter sakazakii and Salmonella Newport infections.

Today's food laboratories remain largely free of regulatory oversight. That is about to change with the Food and Drug Administration's (FDA's) issuance of a final rule establishing a program for the testing of food, in certain circumstances, by accredited laboratories. Not only does this final rule provide specific quality standards and assurances to a segment of food testing, but it also opens the door for all laboratories to adhere to these essential elements.

This column will expand on the findings of the FDA study of the economic evaluation of the GenomeTrakr whole genome sequencing (WGS) program, adding data on the use of sequencing and how it will continue to change food safety practices and markets. It will also discuss what FDA is doing with GenomeTrackr to uncover previously unseen outbreaks and how this is keeping pressure on processors to expand environmental monitoring and controls.

On February 15, the U.S. Senate voted to narrowly confirm Dr. Robert Califf as Commissioner of the U.S. Food and Drug Administration (FDA).

The U.S. Food and Drug Administration (FDA) has released guidance intended to help food producers and processors who handle foods that may contain residues of the pesticide chemical chlorpyrifos.

Food Safety Matters welcomes Erik Mettler and Michael Rogers with FDA's Office of Regulatory Affairs and Travis Waller with the Utah Department of Agriculture and Food to discuss the Domestic Mutual Reliance program and the many benefits of formal agreements between FDA and state partners.
 

The U.S. Food and Drug Administration (FDA) released a new video that includes information about the 2021 Food Allergy Safety, Treatment, Education, and Research (FASTER) Act.

The U.S. Food and Drug Administration (FDA) has debuted a list of draft and final guidance topics that it will prioritize in 2022.